SOTIO is developing the next generation of potent immunotherapies for patients with cancer. To achieve this goal, we intend to acquire therapeutic oncology assets that are at advanced preclinical or clinical stages to include in our portfolio. We are looking for differentiated drugs of varying modalities (small molecules, biologics, cell therapies, etc.) that have the potential to make a real difference in patients suffering from cancer.
SOTIO has offices and research laboratories located in Prague (Czech Republic) and in Cambridge, MA. Both facilities collaborate with leading research teams and hospitals in the US and Europe. In 2020, the company opened offices in Basel (Switzerland) to accelerate development of its pipeline products. SOTIO has also direct access to the GMP manufacturing capabilities in Prague.
U nás se domluvíte jazyky
Naše pracovní příležitosti
Novinky od SOTIO Biotech
Nelisa: Právě jsme přidali novou nabídku Senior Scientist🧑🔬 IHC & Dx development in our Prague based team 🔬 It is more than a job! .